Digital Biomanufacturing Market to Grow with a CAGR of 14.40% through 2030
Rising automation process
and technological advancements to drive the digital biomanufacturing market in
the forecast period, 2026-2030.
According to TechSci Research
report, “Digital Biomanufacturing Market - Global Industry
Size, Share, Trends, Opportunity, and Forecast, 2030”, the Global Digital Biomanufacturing Market was valued at USD 2.24 billion in 2024 and is expected to reach USD 5.02 billion by 2030 with a CAGR of 14.40% during the forecast period. The constant shift toward digitalization and
biomanufacturing in the healthcare industry and rising automation process in
various industries are the primary factors driving the demand for the global digital
biomanufacturing market. Growing technological advancements, innovative
breakthroughs in computational chemistry, rising emphasis on reduction in cost
and time, and rising investments on R&D activities are expected to
influence the market demand. Also, the growing strategic acquisitions and
collaboration between companies are a key factor for increasing the growth of the
market, globally.
However, the The lack of technology
adoption and awareness leading to low return-of-investments and lack of data
security in biomanufacturing settings may likely hamper the growth of the
global digital biomanufacturing market.
Browse over XX market
data Figures spread through XX Pages and an in-depth TOC on "Global
Digital Biomanufacturing Market"
The global
digital biomanufacturing market is segmented into technology, application, end
user, regional distribution, and company.
Based on Application, Bioprocess Optimization and Process Analytics is experiencing the fastest growth globally. This category focuses on leveraging digital technologies such as real-time sensors, predictive modeling, AI, and data analytics to improve process efficiency, ensure product quality, and reduce manufacturing costs. The rapid expansion of complex biologics, cell and gene therapies, and personalized medicines has increased the demand for precise, data-driven process control. Regulatory agencies such as the FDA and EMA emphasize the importance of process understanding, risk-based monitoring, and data-driven validation. Manufacturers adopting bioprocess optimization and analytics can meet these requirements effectively by predicting process deviations, optimizing media feeds, and minimizing batch failures, all while complying with Good Manufacturing Practice (GMP) standards.
Based on Region, The Asia-Pacific region is emerging as the fastest-growing market for digital biomanufacturing, driven by a combination of increasing healthcare investments, rapid industrialization, rising biological production, and supportive government policies. Countries such as China, India, Japan, and South Korea are actively expanding their biomanufacturing capabilities, modernizing facilities, and adopting digital platforms to meet the growing demand for biologics, vaccines, and advanced therapies. Government initiatives are a major driver. China, for example, has implemented policies to support domestic vaccine and biologics production, including funding for digital upgrades, automation, and process analytical technologies (PAT). India’s National Biotechnology Development Strategy emphasizes the adoption of advanced manufacturing technologies, workforce development, and enhanced regulatory frameworks to promote safe and efficient biologics production. Japan has also invested heavily in upgrading biomanufacturing infrastructure with digital solutions to address the needs of an aging population and increase manufacturing efficiency.
Major operating
companies operating in Global Digital Biomanufacturing Market are:
- Agilent Technologies, Inc.
- Danaher Corporation
- Donaldson Company, Inc.
- SAP SE
- Honeywell International Inc.
- Emerson Electric Company
- Siemens Healthineers AG
- Atos SE
- GE Healthcare
- e-matica srl
Download Free Sample Report
Customers can
also request for 10% free customization on this report.
“North America region
dominates the market in and is expected to maintain its dominance in the
coming years due to its sophisticated healthcare system and substantial demand
for biologics. The increasing number of company collaborations, rise in R&D investment by governments, advanced knowledge of cutting-edge technology, and advancement in technology are propelling the market
growth. Also, growing government emphasis on supply chain collaboration,
automation, and robotics in the region are expected to propel the global digital
biomanufacturing market growth till 2030” said Mr. Karan Chechi, Research
Director of TechSci Research, a research based global management consulting
firm.
“Digital Biomanufacturing
Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Technology (AI & IOMT Solutions, Process Analytical
Technologies, Data Analytics Software, Others), By Application
(Biomanufacturing Process Automation and Control, Bioprocess Optimization and
Process Analytics, Flexible Manufacturing), By End User (Biotechnology &
Pharmaceutical Companies, Academic & Research Institutions, Others), By Region and Competition, 2020-2030F”, has evaluated the future
growth potential of global digital biomanufacturing market and provides
statistics & information on market size, structure, and future market
growth. The report intends to provide cutting-edge market intelligence and help
decision makers take sound investment decisions. Besides, the report also
identifies and analyzes the emerging trends along with essential drivers,
challenges, and opportunities in global digital biomanufacturing market.
Contact
TechSci Research LLC
420 Lexington Avenue, Suite 300,
New York, United States- 10170
Tel: +1-332-258-6602
Email: [email protected]
Website: www.techsciresearch.com